×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
The long tail of oncogenic drivers in prostate cancer.
29610475
2018
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
The long tail of oncogenic drivers in prostate cancer.
29610475
2018
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
25970160
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Integrative molecular profiling of routine clinical prostate cancer specimens.
25735316
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.
25908785
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
25970160
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Integrative molecular profiling of routine clinical prostate cancer specimens.
25735316
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.
25908785
2015
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).
25062956
2014
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).
25062956
2014
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.
23704919
2013
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.
23704919
2013
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Successful Treatment of Advanced Metastatic Prostate Cancer following Chemotherapy Based on Molecular Profiling.
22666205
2012
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Successful Treatment of Advanced Metastatic Prostate Cancer following Chemotherapy Based on Molecular Profiling.
22666205
2012
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
22610119
2012
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
22610119
2012
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
20729295
2010
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
20729295
2010
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
19011039
2009
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
19011039
2009
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer.
18829485
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer.
18829485
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
17141945
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Therapeutic
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Prostatic Neoplasms
0.600
Biomarker
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774
2007